|
Volumn 46, Issue 3, 2002, Pages 929-931
|
In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
GERANYLTRANSFERASE;
PAMIDRONIC ACID;
RISEDRONIC ACID;
STIBOGLUCONATE SODIUM;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIPROTOZOAL ACTIVITY;
ARTICLE;
BODY WEIGHT;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
ENZYME INHIBITION;
FEMALE;
IN VIVO STUDY;
LEISHMANIA DONOVANI;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
TOXOPLASMA GONDII;
ADMINISTRATION, ORAL;
ALENDRONATE;
ALKYL AND ARYL TRANSFERASES;
ANIMALS;
CRICETINAE;
DIPHOSPHONATES;
ENZYME INHIBITORS;
FEMALE;
GERANYLTRANSTRANSFERASE;
INJECTIONS, INTRAPERITONEAL;
LEISHMANIA DONOVANI;
LEISHMANIASIS, VISCERAL;
MESOCRICETUS;
MICE;
MICE, INBRED BALB C;
PRODRUGS;
SURVIVAL ANALYSIS;
TOXOPLASMA;
TOXOPLASMOSIS, ANIMAL;
|
EID: 0036171419
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.3.929-931.2002 Document Type: Article |
Times cited : (123)
|
References (6)
|